# Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients

> **NCT05964153** · NA · UNKNOWN · sponsor: **Corporacion Parc Tauli** · enrollment: 10 (estimated)

## Conditions studied

- Glioma
- Circulating Tumor Cell

## Interventions

- **DIAGNOSTIC_TEST:** Liquid Biopsy

## Key facts

- **NCT ID:** NCT05964153
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-31
- **Primary completion:** 2023-07-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05964153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05964153, "Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05964153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*